CYP2F2P: A Drug Target / Disease Biomarker (G171427)

Target Name: CYP2F2P

NCBI ID: G171427

CYP2F2P

Other Name(s): cytochrome P450 family 2 subfamily F member 2, pseudogene | CYP2F1P | Cytochrome P450 family 2 subfamily F member 2, pseudogene

CYP2F2P: A Drug Target / Disease Biomarker

CYP2F2P is a protein that is expressed in many tissues throughout the body, including the brain, heart, liver, and kidneys. It is a key regulator of the blood-brain barrier, which is responsible for controlling the movement of substances into and out of the brain.

One of the things that makes CYP2F2P so important is its role in controlling the access of drugs to the brain. Many drugs that are used to treat various neurological and psychiatric disorders work by altering the levels of certain proteins in the brain, including CYP2F2P.

For example, the drug Valproate is used to treat epilepsy and certain forms of depression. It works by inhibiting the activity of CYP2F2P, which in turn allows the drug to cross the blood-brain barrier and reach the affected cells.

Another drug that is known to work by interacting with CYP2F2P is the antidepressant drug fluoxetine (Prozac). This drug works by inhibiting the activity of CYP2F2P, which can help to reduce the amount of this protein in the brain.

CYP2F2P is also an important biomarker for many diseases, including epilepsy, schizophrenia, and depression. Researchers are interested in using CYP2F2P as a potential target for new drugs because of its role in these diseases.

One of the challenges in studying CYP2F2P is its complex structure. CYP2F2P is a transmembrane protein, which means that it spans the membrane of the brain and other tissues. This makes it difficult to study because it is hard to detect changes in the levels of this protein in different parts of the body.

However, researchers are making progress in understanding how CYP2F2P works. They have identified a number of different ways that CYP2F2P can interact with other proteins in the brain, and they are developing new techniques for studying its function.

One of the most promising areas of research is the study of CYP2F2P's role in the development and progression of neurological disorders. For example, some studies have suggested that changes in the levels of CYP2F2P may be involved in the development of Alzheimer's disease and other forms of dementia.

Another area of research that is of interest to researchers is the study of CYP2F2P's role in drug development. As mentioned earlier, many drugs that are used to treat various neurological and psychiatric disorders work by altering the levels of certain proteins in the brain, including CYP2F2P. Researchers are interested in using CYP2F2P as a potential target for new drugs because of its role in these diseases.

Overall, CYP2F2P is a protein that is important for many different functions in the body, including the regulation of the blood-brain barrier and the development and progression of neurological disorders. As research continues to advance, it is likely that we will learn more about the role of CYP2F2P in these processes and the potential applications of this protein as a drug target.

Protein Name: Cytochrome P450 Family 2 Subfamily F Member 2, Pseudogene

The "CYP2F2P Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYP2F2P comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets